홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → HCID 178492230, 화합물

HRID 1621457
인쇄

반응식

HRID 1621457 반응식
[CH3:1][O:2][C:3]1[N:8]=[CH:7][C:6]([NH:9][C:10]2[C:17]([C:18]3[N:26]=[C:25]([CH3:27])[N:24]=[C:23]4[C:19]=3[N:20]=[CH:21][N:22]4C3CCCCO3)=[CH:16][C:13]([CH:14]=O)=[CH:12][N:11]=2)=[CH:5][CH:4]=1.[CH3:34][O:35][C:36]1[CH:42]=[CH:41][C:39]([NH2:40])=[CH:38][CH:37]=1.[BH4-].[Na+].Cl>CCO.C(O[Ti](OC(C)C)(OC(C)C)OC(C)C)(C)C.O.CO.C(Cl)Cl>[CH3:34][O:35][C:36]1[CH:42]=[CH:41][C:39]([NH:40][CH2:14][C:13]2[CH:16]=[C:17]([C:18]3[N:26]=[C:25]([CH3:27])[N:24]=[C:23]4[C:19]=3[N:20]=[CH:21][NH:22]4)[C:10]([NH:9][C:6]3[CH:7]=[N:8][C:3]([O:2][CH3:1])=[CH:4][CH:5]=3)=[N:11][CH:12]=2)=[CH:38][CH:37]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 4

HCID 313Hydrochloric AcidHCID 7732P-AnisidineHCID 4311764Sodium borohydrideHCID 595483516-(6-Methoxypyridin-3-ylamino)-5-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)nicotinaldehyde

생성물 1

HCID 178492230HCID 178492230, 화합물수율 76%

시약·촉매·용매 5

HCID 178460666
HCID 178460666, 화합물
촉매
HCID 702Ethanol용매
HCID 887Methanol용매
HCID 962Water용매
HCID 6344Dichloromethane용매2회

실험 절차

6-(6-Methoxypyridin-3-ylamino)-5-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)nicotinaldehyde (187.1 mg, 0.4200 mmol) was suspended in EtOH (3.8 mL) and tetraisopropoxytitanium (Fluka, Buchs, Switzerland, 0.25 mL, 0.84 mmol) and 4-methoxyaniline (Aldrich, St. Louis, Mo., 81.9 mg, 0.665 mmol) were added. DCM (2 mL) was added about 15 minutes later, and the reaction was stirred under nitrogen at room temperature overnight. Then, sodium borohydride (36 mg, 0.95 mmol) was added along with DCM (3 mL), and stirring was continued at room temperature, resulting in precipitation. After stirring for 1 hour, the suspension was treated with MeOH (1.5 mL) and 5N HCl (0.60 mL). Stirring was continued at room temperature overnight. Then, the reaction was treated with water (20 mL) and filtered, and the solid was washed with water. The solid and unfiltered material were combined, concentrated, and treated with MeOH, and filtered. The filtration was sluggish, so instead the suspension was concentrated, treated with TFA and DMSO, and filtered with DCM and MeOH. This filtration was also sluggish, so the suspension was filtered instead through a Celite® (diatomaceous earth) pad. The filtrate was concentrated, but could not be filtered for HPLC purification despite treatment with DMSO, TFA, MeOH, and DCM. So, this solution was concentrated, and the fine suspension was filtered through a Celite® (diatomaceous earth) pad. This filtrate was purified by prep HPLC (10% to 100% MeCN/water with 0.1% TFA over 30 minutes with a total flow rate of 100 mL/min) to give 5-((4-methoxyphenylamino)methyl)-N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine (149.4 mg, 76% yield). MS (ESI pos. ion) m/z 469 (M+H)+. 1H NMR (d6-DMSO, 400 MHz) δ 12.60 (s, 1H), 9.72 (s, 1H), 8.62 (s, 1H), 8.53 (d, J=2.54 Hz, 1H), 8.27 (s, 1H), 8.14 (dd, J=9.10 Hz, 2.45 Hz, 1H), 7.22 (s, 1H), 7.09 (s, 1H), 6.97 (s, 2H), 6.90-6.80 (m 3H), 4.38 (s, 2H), 3.85 (s, 3H), 3.67 (s, 3H), 2.85 (s, 3H).

후처리

  1. stirringstirring
  2. customwas continued at room temperature
  3. customresulting in precipitation
  4. stirringAfter stirring for 1 hour
  5. stirringStirring
  6. waitwas continued at room temperature overnight
  7. filtrationfiltered
  8. washthe solid was washed with water
  9. concentrationconcentrated
  10. additiontreated with MeOH
  11. filtrationfiltered
  12. filtrationThe filtration
  13. concentrationso instead the suspension was concentrated
  14. additiontreated with TFA and DMSO
  15. filtrationfiltered with DCM and MeOH
  16. filtrationThis filtration
  17. filtrationso the suspension was filtered instead through a Celite® (diatomaceous earth) pad
  18. concentrationThe filtrate was concentrated
  19. filtrationcould not be filtered for HPLC purification despite treatment with DMSO, TFA, MeOH, and DCM
  20. concentrationSo, this solution was concentrated
  21. filtrationthe fine suspension was filtered through a Celite® (diatomaceous earth) pad
  22. customThis filtrate was purified by prep HPLC (10% to 100% MeCN/water with 0.1% TFA over 30 minutes with a total flow rate of 100 mL/min)

출처 및 근거

ORD 기록
ord-629a547dd33e4e2b81f9edb0e6467304
출처 데이터셋
uspto-grants-2014_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08772480B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트